Search
Now showing items 1-3 of 3
MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
(BMC Cancer, 2010-09-01)
BACKGROUND: Glioblastoma multiforme (GBM) is refractory to conventional therapies.
To overcome the problem of heterogeneity, more brain tumor markers are required for
prognosis and targeted therapy. We have identified and ...
MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
(BMC Cancer, 2010-09-01)
BACKGROUND: Glioblastoma multiforme (GBM) is refractory to conventional therapies.
To overcome the problem of heterogeneity, more brain tumor markers are required for
prognosis and targeted therapy. We have identified and ...
Targeting A20 decreases glioma stem cell survival and tumor growth.
(PLoS Biol, 2010-02-23)
Glioblastomas are deadly cancers that display a functional cellular hierarchy maintained
by self-renewing glioblastoma stem cells (GSCs). GSCs are regulated by molecular pathways
distinct from the bulk tumor that may be ...